Combination of microRNA expression profiling with genome-wide SNP genotyping to construct a coronary artery disease-related miRNA-miRNA synergistic network.

In recent years, microRNAs (miRNAs) were found to play critical roles in many important biological processes. On the other hand, the rapid development of genome-wide association studies (GWAS) help identify potential genetic variants associated with the disease phenotypic variance. Therefore, we suggested a combined analysis of microRNA expression profiling with genome-wide Single Nucleotide Polymorphism (SNP) genotyping to identify potential disease-related biomarkers. Considering functional SNPs in miRNA genes or target sites might be important signals associated with human complex diseases, we constructed a miRNA-miRNA synergistic network related to coronary artery disease (CAD) by performing a genome-wide scan for SNPs in human miRNA 3' -untranslated regions (UTRs) target sites and computed potential SNP cooperation effects contributing to disease based on potential miRNA-SNP interactions reported recently. Furthermore, we identified some potential CAD-related miRNAs by analyzing the constructed miRNAmiRNA synergistic network. As a result, the predicted miRNA-miRNA network and miRNA clusters were validated by significantly high interaction effects of CAD-related miRNAs. Accurate classification performances were obtained for all of the identified miRNA clusters, and the sensitivity and specificity were all more than 90%. The network topological analysis confirmed some novel CAD-related miRNAs identified recently by experiments. Our method might help to understand miRNA function and CAD disease, as well as to explore the novel mechanisms involved.

[1]  E. Bronze-da-Rocha MicroRNAs Expression Profiles in Cardiovascular Diseases , 2014, BioMed research international.

[2]  A. Stewart,et al.  Genetics of Coronary Artery Disease in the 21st Century , 2012, Clinical cardiology.

[3]  Mario Medvedovic,et al.  Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. , 2012, Cardiovascular research.

[4]  Nicholas R. Lemoine,et al.  SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update) , 2012, Nucleic Acids Res..

[5]  W. Min,et al.  Mirtron MicroRNA-1236 Inhibits VEGFR-3 Signaling During Inflammatory Lymphangiogenesis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Hong-Mei Zhang,et al.  Genome‐wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis , 2012, Human mutation.

[7]  S. Fichtlscherer,et al.  Transcoronary Concentration Gradients of Circulating MicroRNAs , 2011, Circulation.

[8]  E. Martin,et al.  Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease , 2011, PloS one.

[9]  O. Fortunato,et al.  Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132 , 2011, Circulation research.

[10]  P. Sethupathy,et al.  Bioinformatic and Genetic Association Analysis of MicroRNA Target Sites in One-Carbon Metabolism Genes , 2011, PloS one.

[11]  Arijit Mukhopadhyay,et al.  miRvar: A comprehensive database for genomic variations in microRNAs , 2011, Human mutation.

[12]  Anil G Jegga,et al.  Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. , 2010, Journal of molecular and cellular cardiology.

[13]  Yun Xiao,et al.  MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features , 2010, Nucleic acids research.

[14]  Momiao Xiong,et al.  A Novel Statistic for Genome-Wide Interaction Analysis , 2010, PLoS genetics.

[15]  Juan Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[16]  C. Harris,et al.  Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.

[17]  Emmette R. Hutchison,et al.  The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration, and Repair , 2009, NeuroMolecular Medicine.

[18]  D. Catalucci,et al.  MicroRNAs in Cardiovascular Biology and Heart Disease , 2009, Circulation. Cardiovascular genetics.

[19]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[20]  Philip S. Yu,et al.  G-SESAME: web tools for GO-term-based gene similarity analysis and knowledge discovery , 2009, Nucleic Acids Res..

[21]  P. Donnelly,et al.  Designing Genome-Wide Association Studies: Sample Size, Power, Imputation, and the Choice of Genotyping Chip , 2009, PLoS genetics.

[22]  Illés J. Farkas,et al.  Human microRNAs co-silence in well-separated groups and have different predicted essentialities , 2009, Bioinform..

[23]  David Warde-Farley,et al.  Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.

[24]  Zhen Liu,et al.  Identifying disease associations via genome-wide association studies , 2009, BMC Bioinformatics.

[25]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[26]  Baofeng Yang,et al.  Constructing disease-specific gene networks using pair-wise relevance metric: Application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements , 2008, BMC Systems Biology.

[27]  R. Xavier,et al.  AKAP13, a RhoA GTPase-specific Guanine Exchange Factor, Is a Novel Regulator of TLR2 Signaling* , 2007, Journal of Biological Chemistry.

[28]  James M Hagberg,et al.  Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults. , 2007, Journal of applied physiology.

[29]  Sek Won Kong,et al.  Altered microRNA expression in human heart disease. , 2007, Physiological genomics.

[30]  Yitzhak Pilpel,et al.  Global and Local Architecture of the Mammalian microRNA–Transcription Factor Regulatory Network , 2007, PLoS Comput. Biol..

[31]  V. Blondel,et al.  Distance distribution in random graphs and application to network exploration. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.

[32]  Edwin Wang,et al.  Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers , 2007, Nucleic acids research.

[33]  N. Rajewsky,et al.  Natural selection on human microRNA binding sites inferred from SNP data , 2006, Nature Genetics.

[34]  E. Olson,et al.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.

[35]  Bradley E. Enerson,et al.  Pathway analysis using random forests classification and regression , 2006, Bioinform..

[36]  Jan Krüger,et al.  RNAhybrid: microRNA target prediction easy, fast and flexible , 2006, Nucleic Acids Res..

[37]  Z. Oltvai,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[38]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[39]  Hugo A. Katus,et al.  MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction , 2010, Basic Research in Cardiology.

[40]  Robert Tibshirani,et al.  The 'miss rate' for the analysis of gene expression data. , 2005, Biostatistics.